Catheter Precision Inc. (AMEX:VTAK) has a beta value of -0.38 and has seen 56944.0 shares traded in the recent trading session. The VTAK stock price is -2170.27% off its 52-week high price of $8.40 and 16.22% above the 52-week low of $0.31. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.12 million shares traded. The 3-month trading volume is 221.40K shares.
Catheter Precision Inc. (AMEX:VTAK) trade information
Sporting 0.29% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the VTAK stock price touched $0.37 or saw a rise of 6.33%. Year-to-date, Catheter Precision Inc. shares have moved -90.75%, while the 5-day performance has seen it change 14.93%. Over the past 30 days, the shares of Catheter Precision Inc. (AMEX:VTAK) have changed -14.71%. Short interest in the company has seen 46547.0 shares shorted with days to cover at 0.1.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Catheter Precision Inc. (VTAK) estimates and forecasts
Figures show that Catheter Precision Inc. shares have outperformed across the wider relevant industry. The company’s shares have lost -91.56% over the past 6 months, with this year growth rate of 92.80%, compared to 13.80% for the industry. Revenue growth from the last financial year stood is estimated to be 621.70%.
1 analysts offering their estimates for the company have set an average revenue estimate of 1.06M for the current quarter. 1 have an estimated revenue figure of 1.66M for the next ending quarter. Year-ago sales stood 133k and 128k respectively for this quarter and the next, and analysts expect sales will grow by 697.00% for the current quarter and 621.70% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 66.41% over the past 5 years.
VTAK Dividends
Catheter Precision Inc. is expected to release its next earnings report on 2024-Dec-19 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Catheter Precision Inc. (AMEX:VTAK)’s Major holders
Insiders own 16.78% of the company shares, while shares held by institutions stand at 2.53% with a share float percentage of 3.04%. Investors are also buoyed by the number of investors in a company, with Catheter Precision Inc. having a total of 13.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund. As of Aug 31, 2024, the former fund manager holds about 0.41% shares in the company for having 4.06 shares of worth $1570.0 while later fund manager owns 48.0 shares of worth $18.0 as of Aug 31, 2024, which makes it owner of about 0.00% of company’s outstanding stock.
